Keywords: mylan, takes, issue, biovail, anda, approval, nifedipine

Mylan takes issue with Biovail's ANDA approval for nifedipine

Article | 14 February 2001

Print This

Mylan Laboratories has said that the US approval of Biovail'sAbbreviated New Drug Application for a generic form of Pfizer's Procardia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in